Related Articles
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer
miR‑342 is associated with estrogen receptor‑α expression and response to tamoxifen in breast cancer
mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer
Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer
p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer